<?xml version="1.0" encoding="UTF-8"?>
<rss version="2.0"
	xmlns:content="http://purl.org/rss/1.0/modules/content/"
	xmlns:wfw="http://wellformedweb.org/CommentAPI/"
	xmlns:dc="http://purl.org/dc/elements/1.1/"
	xmlns:atom="http://www.w3.org/2005/Atom"
	xmlns:sy="http://purl.org/rss/1.0/modules/syndication/"
	xmlns:slash="http://purl.org/rss/1.0/modules/slash/"
	>

<channel>
	<title>PILMAN &#187; reality</title>
	<atom:link href="http://www.tapanray.in/tag/reality/feed/" rel="self" type="application/rss+xml" />
	<link>http://www.tapanray.in</link>
	<description>A Tapan Ray Website</description>
	<lastBuildDate>Sun, 22 Mar 2026 10:59:18 +0000</lastBuildDate>
	<language>en-US</language>
	<sy:updatePeriod>hourly</sy:updatePeriod>
	<sy:updateFrequency>1</sy:updateFrequency>
	<generator>http://wordpress.org/?v=3.4.2</generator>
		<item>
		<title>&#8216;Indian Pharma’s Apathy Towards Digital Marketing’ &#8211; A Misgiving Or Real?</title>
		<link>http://www.tapanray.in/indian-pharmas-apathy-towards-digital-marketing-a-misgiving-or-real/?utm_source=rss&#038;utm_medium=rss&#038;utm_campaign=indian-pharmas-apathy-towards-digital-marketing-a-misgiving-or-real</link>
		<comments>http://www.tapanray.in/indian-pharmas-apathy-towards-digital-marketing-a-misgiving-or-real/#comments</comments>
		<pubDate>Fri, 02 Jun 2023 06:18:14 +0000</pubDate>
		<dc:creator>Tapan Ray</dc:creator>
				<category><![CDATA[Pharma]]></category>
		<category><![CDATA[analytics]]></category>
		<category><![CDATA[apathy]]></category>
		<category><![CDATA[companies]]></category>
		<category><![CDATA[digital]]></category>
		<category><![CDATA[Drug]]></category>
		<category><![CDATA[India]]></category>
		<category><![CDATA[industry]]></category>
		<category><![CDATA[marketing]]></category>
		<category><![CDATA[misgiving]]></category>
		<category><![CDATA[Ray]]></category>
		<category><![CDATA[REAL]]></category>
		<category><![CDATA[reality]]></category>
		<category><![CDATA[Tapan]]></category>
		<category><![CDATA[Tapan Ray]]></category>
		<category><![CDATA[tools]]></category>

		<guid isPermaLink="false">http://www.tapanray.in/?p=10794</guid>
		<description><![CDATA[As I gather from different sources, an increasing number of Indian pharma companies are increasingly embracing digitalization in their marketing operations, especially after the crippling experience during the Covid lockdown period. They realize the use of digital platforms would be a great &#8230; <a href="http://www.tapanray.in/indian-pharmas-apathy-towards-digital-marketing-a-misgiving-or-real/">Continue reading <span class="meta-nav">&#8594;</span></a>]]></description>
		<wfw:commentRss>http://www.tapanray.in/indian-pharmas-apathy-towards-digital-marketing-a-misgiving-or-real/feed/</wfw:commentRss>
		<slash:comments>0</slash:comments>
		</item>
		<item>
		<title>Creative Pharma Marketers To Unshackle Covid Fetters</title>
		<link>http://www.tapanray.in/creative-pharma-marketers-to-unshackle-covid-fetters/?utm_source=rss&#038;utm_medium=rss&#038;utm_campaign=creative-pharma-marketers-to-unshackle-covid-fetters</link>
		<comments>http://www.tapanray.in/creative-pharma-marketers-to-unshackle-covid-fetters/#comments</comments>
		<pubDate>Mon, 09 Nov 2020 00:00:55 +0000</pubDate>
		<dc:creator>Tapan Ray</dc:creator>
				<category><![CDATA[Pharma]]></category>
		<category><![CDATA[care]]></category>
		<category><![CDATA[clinic]]></category>
		<category><![CDATA[colossal]]></category>
		<category><![CDATA[Coronavirus]]></category>
		<category><![CDATA[Covid]]></category>
		<category><![CDATA[COVID-19]]></category>
		<category><![CDATA[creative]]></category>
		<category><![CDATA[doctor]]></category>
		<category><![CDATA[Drug]]></category>
		<category><![CDATA[Fetters]]></category>
		<category><![CDATA[Health]]></category>
		<category><![CDATA[in-person]]></category>
		<category><![CDATA[India]]></category>
		<category><![CDATA[limitations]]></category>
		<category><![CDATA[marketers]]></category>
		<category><![CDATA[marketing]]></category>
		<category><![CDATA[overcome]]></category>
		<category><![CDATA[pandemic]]></category>
		<category><![CDATA[Patients]]></category>
		<category><![CDATA[physicians]]></category>
		<category><![CDATA[Ray]]></category>
		<category><![CDATA[reality]]></category>
		<category><![CDATA[strategies]]></category>
		<category><![CDATA[Tapan]]></category>
		<category><![CDATA[Tapan Ray]]></category>
		<category><![CDATA[task]]></category>
		<category><![CDATA[Telehealth]]></category>
		<category><![CDATA[telemedicine]]></category>
		<category><![CDATA[Unshackle]]></category>
		<category><![CDATA[visits]]></category>
		<category><![CDATA[win-win]]></category>

		<guid isPermaLink="false">http://www.tapanray.in/?p=10317</guid>
		<description><![CDATA[Pharma industry, just as most others, has started recognizing that the business needs to be brought back to normal, despite Covid fetters. Some early evidences suggest, a new breed of pharma marketers is refusing to get confined to Covid triggered &#8230; <a href="http://www.tapanray.in/creative-pharma-marketers-to-unshackle-covid-fetters/">Continue reading <span class="meta-nav">&#8594;</span></a>]]></description>
		<wfw:commentRss>http://www.tapanray.in/creative-pharma-marketers-to-unshackle-covid-fetters/feed/</wfw:commentRss>
		<slash:comments>0</slash:comments>
		</item>
		<item>
		<title>Prescription Digital Therapy Now A Reality</title>
		<link>http://www.tapanray.in/prescription-digital-therapy-now-a-reality/?utm_source=rss&#038;utm_medium=rss&#038;utm_campaign=prescription-digital-therapy-now-a-reality</link>
		<comments>http://www.tapanray.in/prescription-digital-therapy-now-a-reality/#comments</comments>
		<pubDate>Mon, 07 May 2018 00:00:46 +0000</pubDate>
		<dc:creator>Tapan Ray</dc:creator>
				<category><![CDATA[Pharma]]></category>
		<category><![CDATA[2]]></category>
		<category><![CDATA[3]]></category>
		<category><![CDATA[app]]></category>
		<category><![CDATA[Apple]]></category>
		<category><![CDATA[approval]]></category>
		<category><![CDATA[behavior]]></category>
		<category><![CDATA[chronic]]></category>
		<category><![CDATA[cognition]]></category>
		<category><![CDATA[diabetic]]></category>
		<category><![CDATA[digiceuticals]]></category>
		<category><![CDATA[digital]]></category>
		<category><![CDATA[disease]]></category>
		<category><![CDATA[disorder]]></category>
		<category><![CDATA[Epilepsy]]></category>
		<category><![CDATA[fitness]]></category>
		<category><![CDATA[Health]]></category>
		<category><![CDATA[India]]></category>
		<category><![CDATA[MDD]]></category>
		<category><![CDATA[mood]]></category>
		<category><![CDATA[Novartis]]></category>
		<category><![CDATA[Parkinson's]]></category>
		<category><![CDATA[Pear]]></category>
		<category><![CDATA[Pears]]></category>
		<category><![CDATA[potential]]></category>
		<category><![CDATA[prescription]]></category>
		<category><![CDATA[Ray]]></category>
		<category><![CDATA[reality]]></category>
		<category><![CDATA[Regulatory]]></category>
		<category><![CDATA[reSet]]></category>
		<category><![CDATA[Sandoz]]></category>
		<category><![CDATA[scope]]></category>
		<category><![CDATA[seizures]]></category>
		<category><![CDATA[Substance]]></category>
		<category><![CDATA[Takeda]]></category>
		<category><![CDATA[Tapan]]></category>
		<category><![CDATA[Tapan Ray]]></category>
		<category><![CDATA[Therapeutics]]></category>
		<category><![CDATA[therapy]]></category>
		<category><![CDATA[use]]></category>
		<category><![CDATA[version]]></category>
		<category><![CDATA[Watch]]></category>
		<category><![CDATA[wealthy]]></category>
		<category><![CDATA[wearable]]></category>

		<guid isPermaLink="false">http://www.tapanray.in/?p=8981</guid>
		<description><![CDATA[The pursuit of offering ‘prescription digital therapeutics’ or ‘digiceuticals’ by Big Pharma, to ensure better clinical outcomes for patients, has apparently come to fruition now. On April 18, 2018, by a media release, Novartis announced that the Sandoz Division of the Company &#8230; <a href="http://www.tapanray.in/prescription-digital-therapy-now-a-reality/">Continue reading <span class="meta-nav">&#8594;</span></a>]]></description>
		<wfw:commentRss>http://www.tapanray.in/prescription-digital-therapy-now-a-reality/feed/</wfw:commentRss>
		<slash:comments>0</slash:comments>
		</item>
		<item>
		<title>Define And Adapt To Reality: Two Pivotal Pharma Leadership Skills For Sustainable Excellence</title>
		<link>http://www.tapanray.in/define-and-adapt-to-reality-two-pivotal-pharma-leadership-skills-for-sustainable-excellence/?utm_source=rss&#038;utm_medium=rss&#038;utm_campaign=define-and-adapt-to-reality-two-pivotal-pharma-leadership-skills-for-sustainable-excellence</link>
		<comments>http://www.tapanray.in/define-and-adapt-to-reality-two-pivotal-pharma-leadership-skills-for-sustainable-excellence/#comments</comments>
		<pubDate>Mon, 10 Apr 2017 00:00:36 +0000</pubDate>
		<dc:creator>Tapan Ray</dc:creator>
				<category><![CDATA[Pharma]]></category>
		<category><![CDATA[adapt]]></category>
		<category><![CDATA[born]]></category>
		<category><![CDATA[CEO]]></category>
		<category><![CDATA[creativity]]></category>
		<category><![CDATA[define]]></category>
		<category><![CDATA[emotional]]></category>
		<category><![CDATA[engagement]]></category>
		<category><![CDATA[EQ]]></category>
		<category><![CDATA[Ethics]]></category>
		<category><![CDATA[Health]]></category>
		<category><![CDATA[Healthcare]]></category>
		<category><![CDATA[heritable]]></category>
		<category><![CDATA[image]]></category>
		<category><![CDATA[inclusive]]></category>
		<category><![CDATA[India]]></category>
		<category><![CDATA[innovation]]></category>
		<category><![CDATA[Intelligence]]></category>
		<category><![CDATA[inward]]></category>
		<category><![CDATA[leaders]]></category>
		<category><![CDATA[leadership]]></category>
		<category><![CDATA[Looking]]></category>
		<category><![CDATA[made]]></category>
		<category><![CDATA[Patent]]></category>
		<category><![CDATA[pivotal]]></category>
		<category><![CDATA[quotient]]></category>
		<category><![CDATA[Ray]]></category>
		<category><![CDATA[reality]]></category>
		<category><![CDATA[self-test]]></category>
		<category><![CDATA[skills]]></category>
		<category><![CDATA[Strategic]]></category>
		<category><![CDATA[Tapan]]></category>
		<category><![CDATA[Tapan Ray]]></category>

		<guid isPermaLink="false">http://www.tapanray.in/?p=8177</guid>
		<description><![CDATA[Max DePree – a much quoted American businessman and author had once said: “The first responsibility of a leader is to define reality.” While defining the reality within the drug industry today, it makes many industry leaders to ponder, despite &#8230; <a href="http://www.tapanray.in/define-and-adapt-to-reality-two-pivotal-pharma-leadership-skills-for-sustainable-excellence/">Continue reading <span class="meta-nav">&#8594;</span></a>]]></description>
		<wfw:commentRss>http://www.tapanray.in/define-and-adapt-to-reality-two-pivotal-pharma-leadership-skills-for-sustainable-excellence/feed/</wfw:commentRss>
		<slash:comments>0</slash:comments>
		</item>
		<item>
		<title>Access to Medicine: Losing Track in Cacophony</title>
		<link>http://www.tapanray.in/access-to-medicine-losing-track-in-cacophony/?utm_source=rss&#038;utm_medium=rss&#038;utm_campaign=access-to-medicine-losing-track-in-cacophony</link>
		<comments>http://www.tapanray.in/access-to-medicine-losing-track-in-cacophony/#comments</comments>
		<pubDate>Mon, 30 Dec 2013 00:00:37 +0000</pubDate>
		<dc:creator>Tapan Ray</dc:creator>
				<category><![CDATA[Pharma]]></category>
		<category><![CDATA[2004]]></category>
		<category><![CDATA[2012]]></category>
		<category><![CDATA[Access]]></category>
		<category><![CDATA[All]]></category>
		<category><![CDATA[ASSOCHAM]]></category>
		<category><![CDATA[back]]></category>
		<category><![CDATA[BRIC]]></category>
		<category><![CDATA[cacophony]]></category>
		<category><![CDATA[calculation]]></category>
		<category><![CDATA[consulting]]></category>
		<category><![CDATA[data]]></category>
		<category><![CDATA[debate]]></category>
		<category><![CDATA[Dinosaurian]]></category>
		<category><![CDATA[direction]]></category>
		<category><![CDATA[drowns]]></category>
		<category><![CDATA[drugs]]></category>
		<category><![CDATA[envelope]]></category>
		<category><![CDATA[expenditure]]></category>
		<category><![CDATA[facilities]]></category>
		<category><![CDATA[Healthcare]]></category>
		<category><![CDATA[IMS]]></category>
		<category><![CDATA[India]]></category>
		<category><![CDATA[indicators]]></category>
		<category><![CDATA[losing]]></category>
		<category><![CDATA[Medicines]]></category>
		<category><![CDATA[millennium]]></category>
		<category><![CDATA[Modern]]></category>
		<category><![CDATA[number]]></category>
		<category><![CDATA[outcome]]></category>
		<category><![CDATA[per capita]]></category>
		<category><![CDATA[perception]]></category>
		<category><![CDATA[Pharmaceuticals]]></category>
		<category><![CDATA[public]]></category>
		<category><![CDATA[Ray]]></category>
		<category><![CDATA[REAL]]></category>
		<category><![CDATA[reality]]></category>
		<category><![CDATA[relationship]]></category>
		<category><![CDATA[Report]]></category>
		<category><![CDATA[situation]]></category>
		<category><![CDATA[Tapan]]></category>
		<category><![CDATA[WHO]]></category>
		<category><![CDATA[World]]></category>

		<guid isPermaLink="false">http://www.tapanray.in/?p=4467</guid>
		<description><![CDATA[Indian Healthcare space is by and large an arena, where perceptions prevail over the changing reality in many important areas. Consequently, fierce discourse in those areas mostly gives rise to a cacophony of ‘Your Perceptions Against Mine’. It is intriguing, why even &#8230; <a href="http://www.tapanray.in/access-to-medicine-losing-track-in-cacophony/">Continue reading <span class="meta-nav">&#8594;</span></a>]]></description>
		<wfw:commentRss>http://www.tapanray.in/access-to-medicine-losing-track-in-cacophony/feed/</wfw:commentRss>
		<slash:comments>0</slash:comments>
		</item>
		<item>
		<title>&#8216;Disease Oriented Treatment&#8217; to &#8216;Patient Oriented Treatment&#8217; &#8211; An evolving trend</title>
		<link>http://www.tapanray.in/the-magic-bullet-could-soon-be-a-reality/?utm_source=rss&#038;utm_medium=rss&#038;utm_campaign=the-magic-bullet-could-soon-be-a-reality</link>
		<comments>http://www.tapanray.in/the-magic-bullet-could-soon-be-a-reality/#comments</comments>
		<pubDate>Mon, 07 Jan 2013 00:00:01 +0000</pubDate>
		<dc:creator>Tapan Ray</dc:creator>
				<category><![CDATA[Pharma]]></category>
		<category><![CDATA[biomarker]]></category>
		<category><![CDATA[breast]]></category>
		<category><![CDATA[bullets]]></category>
		<category><![CDATA[Cameron]]></category>
		<category><![CDATA[cancer]]></category>
		<category><![CDATA[colorectal]]></category>
		<category><![CDATA[conventional]]></category>
		<category><![CDATA[David]]></category>
		<category><![CDATA[disease-oriented]]></category>
		<category><![CDATA[diseases]]></category>
		<category><![CDATA[Economist]]></category>
		<category><![CDATA[FDA]]></category>
		<category><![CDATA[GeneWatch]]></category>
		<category><![CDATA[India]]></category>
		<category><![CDATA[intractable]]></category>
		<category><![CDATA[magic]]></category>
		<category><![CDATA[Medicines]]></category>
		<category><![CDATA[patient-oriented]]></category>
		<category><![CDATA[personalised]]></category>
		<category><![CDATA[personalized]]></category>
		<category><![CDATA[Pharmaceuticals]]></category>
		<category><![CDATA[PM]]></category>
		<category><![CDATA[Ray]]></category>
		<category><![CDATA[reality]]></category>
		<category><![CDATA[soon]]></category>
		<category><![CDATA[Tapan]]></category>
		<category><![CDATA[treatment]]></category>
		<category><![CDATA[UK]]></category>
		<category><![CDATA[unconventional]]></category>
		<category><![CDATA[US]]></category>
		<category><![CDATA[warfarin]]></category>

		<guid isPermaLink="false">http://tapanray.in/index.php/?p=1381</guid>
		<description><![CDATA[The quest for moving away from conventional and error-prone &#8216;Disease Oriented Treatment&#8217; paving the way for unconventional individual patient-specific ones, may soon come to fruition. Dramatic progress in the research for developing ‘Personalized Medicines&#8217; could soon offer a choice for &#8230; <a href="http://www.tapanray.in/the-magic-bullet-could-soon-be-a-reality/">Continue reading <span class="meta-nav">&#8594;</span></a>]]></description>
		<wfw:commentRss>http://www.tapanray.in/the-magic-bullet-could-soon-be-a-reality/feed/</wfw:commentRss>
		<slash:comments>0</slash:comments>
		</item>
		<item>
		<title>Regulatory Data Protection (RDP) and its need in India: The Myth versus Reality</title>
		<link>http://www.tapanray.in/regulatory-data-protection-rdp-and-its-need-in-india-the-myth-versus-reality/?utm_source=rss&#038;utm_medium=rss&#038;utm_campaign=regulatory-data-protection-rdp-and-its-need-in-india-the-myth-versus-reality</link>
		<comments>http://www.tapanray.in/regulatory-data-protection-rdp-and-its-need-in-india-the-myth-versus-reality/#comments</comments>
		<pubDate>Tue, 08 Dec 2009 07:13:04 +0000</pubDate>
		<dc:creator>Tapan Ray</dc:creator>
				<category><![CDATA[Pharma]]></category>
		<category><![CDATA[2005]]></category>
		<category><![CDATA[Act]]></category>
		<category><![CDATA[China]]></category>
		<category><![CDATA[compliant]]></category>
		<category><![CDATA[data]]></category>
		<category><![CDATA[Exclusivity]]></category>
		<category><![CDATA[in]]></category>
		<category><![CDATA[India]]></category>
		<category><![CDATA[its]]></category>
		<category><![CDATA[Myth]]></category>
		<category><![CDATA[need]]></category>
		<category><![CDATA[pharmacuticals]]></category>
		<category><![CDATA[Product]]></category>
		<category><![CDATA[Protection]]></category>
		<category><![CDATA[Ray]]></category>
		<category><![CDATA[RDP]]></category>
		<category><![CDATA[reality]]></category>
		<category><![CDATA[Regulatory]]></category>
		<category><![CDATA[secret]]></category>
		<category><![CDATA[Tapan]]></category>
		<category><![CDATA[Trade]]></category>
		<category><![CDATA[TRIPS]]></category>
		<category><![CDATA[USA]]></category>
		<category><![CDATA[versus]]></category>
		<category><![CDATA[WTO]]></category>

		<guid isPermaLink="false">http://tapanray.in/index.php/?p=703</guid>
		<description><![CDATA[THE MYTH: An attempt to delay the launch of Indian generics: Some in India feel that Regulatory Data Protection (RDP), is a deliberate attempt by the innovator companies to delay the launch of the generic equivalent of patented products in &#8230; <a href="http://www.tapanray.in/regulatory-data-protection-rdp-and-its-need-in-india-the-myth-versus-reality/">Continue reading <span class="meta-nav">&#8594;</span></a>]]></description>
		<wfw:commentRss>http://www.tapanray.in/regulatory-data-protection-rdp-and-its-need-in-india-the-myth-versus-reality/feed/</wfw:commentRss>
		<slash:comments>0</slash:comments>
		</item>
		<item>
		<title>Regulatory Data Protection (RDP) and its need in India: The Myth versus Reality</title>
		<link>http://www.tapanray.in/regulatory-data-protection-rdp-and-its-need-in-india-the-myth-versus-reality-2/?utm_source=rss&#038;utm_medium=rss&#038;utm_campaign=regulatory-data-protection-rdp-and-its-need-in-india-the-myth-versus-reality-2</link>
		<comments>http://www.tapanray.in/regulatory-data-protection-rdp-and-its-need-in-india-the-myth-versus-reality-2/#comments</comments>
		<pubDate>Mon, 07 Dec 2009 01:00:24 +0000</pubDate>
		<dc:creator>Tapan Ray</dc:creator>
				<category><![CDATA[Pharma]]></category>
		<category><![CDATA[2005]]></category>
		<category><![CDATA[Act]]></category>
		<category><![CDATA[China]]></category>
		<category><![CDATA[compliant]]></category>
		<category><![CDATA[data]]></category>
		<category><![CDATA[Exclusivity]]></category>
		<category><![CDATA[in]]></category>
		<category><![CDATA[India]]></category>
		<category><![CDATA[its]]></category>
		<category><![CDATA[Myth]]></category>
		<category><![CDATA[need]]></category>
		<category><![CDATA[pharmacuticals]]></category>
		<category><![CDATA[Product]]></category>
		<category><![CDATA[Protection]]></category>
		<category><![CDATA[Ray]]></category>
		<category><![CDATA[RDP]]></category>
		<category><![CDATA[reality]]></category>
		<category><![CDATA[Regulatory]]></category>
		<category><![CDATA[secret]]></category>
		<category><![CDATA[Tapan]]></category>
		<category><![CDATA[Trade]]></category>
		<category><![CDATA[TRIPS]]></category>
		<category><![CDATA[USA]]></category>
		<category><![CDATA[versus]]></category>
		<category><![CDATA[WTO]]></category>

		<guid isPermaLink="false">http://tapanray.in/index.php/?p=706</guid>
		<description><![CDATA[THE MYTH: An attempt to delay the launch of Indian generics: Some in India feel that Regulatory Data Protection (RDP), is a deliberate attempt by the innovator companies to delay the launch of the generic equivalent of patented products in &#8230; <a href="http://www.tapanray.in/regulatory-data-protection-rdp-and-its-need-in-india-the-myth-versus-reality-2/">Continue reading <span class="meta-nav">&#8594;</span></a>]]></description>
		<wfw:commentRss>http://www.tapanray.in/regulatory-data-protection-rdp-and-its-need-in-india-the-myth-versus-reality-2/feed/</wfw:commentRss>
		<slash:comments>0</slash:comments>
		</item>
	</channel>
</rss>
